Medicare Enrolled

Dr. Clayton Blankenship, NP

Nurse Practitioner - Family · Bakersfield, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
8329 BRIMHALL RD STE 801, Bakersfield, CA 93312
6616958385
In practice since 2015 (11 years)
NPI: 1790178440 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Blankenship from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Blankenship? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Blankenship

Dr. Clayton Blankenship is a nurse practitioner - family in Bakersfield, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Blankenship performed 22,045 Medicare services across 958 unique beneficiaries.

Between the years covered by Open Payments, Dr. Blankenship received a total of $10,884 from 29 pharmaceutical and/or device companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Blankenship is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 1% volume in CA $10,884 industry payments

Medicare Practice Summary

Medicare Utilization ↗
22,045
Medicare services
Top 1% in CA for nurse practitioner - family
958
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,004 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
7,975 $34 $72
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
7,400 $10 $40
Denosumab injection (Prolia/Xgeva) 3,000 $18 $30
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
2,070 $26 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
738 $67 $200
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
274 $95 $300
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
166 $10 $50
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
98 $9 $20
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
87 $20 $60
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
84 $40 $150
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
58 $11 $60
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
44 $18 $100
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
33 $53 $125
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
18 $4 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
80.4% high complexity
15.7% medium
3.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,884
Total received (2021-2024)
Avg $2,721/year across 4 years
Top 1% in CA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
612
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,884 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,167
2023
$2,365
2022
$2,578
2021
$2,774

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$736
Amgen Inc.
$606
Janssen Biotech, Inc.
$420
Lilly USA, LLC
$170
Aurinia Pharma U.S., Inc.
$154
UCB, Inc.
$135
ANI Pharmaceuticals, Inc.
$133
GlaxoSmithKline, LLC.
$132
E.R. Squibb & Sons, L.L.C.
$129
AstraZeneca Pharmaceuticals LP
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$97
Fresenius Kabi USA, LLC
$82
Novartis Pharmaceuticals Corporation
$60
Octapharma USA, Inc.
$58
PFIZER INC.
$57
Mallinckrodt Hospital Products Inc.
$57
Kiniksa Pharmaceuticals International, plc
$19
Fidia Pharma USA Inc.
$16
Top 3 companies account for 55.6% of 2024 payments
All-time payments by company (2021-2024) ›
Amgen Inc.
$2,320
ABBVIE INC.
$1,996
Janssen Biotech, Inc.
$1,581
AbbVie Inc.
$606
GlaxoSmithKline, LLC.
$589
Aurinia Pharma U.S., Inc.
$504
AstraZeneca Pharmaceuticals LP
$455
Novartis Pharmaceuticals Corporation
$444
E.R. Squibb & Sons, L.L.C.
$373
Genentech USA, Inc.
$299
Horizon Therapeutics plc
$293
Lilly USA, LLC
$251
ANI Pharmaceuticals, Inc.
$221
UCB, Inc.
$160
Boehringer Ingelheim Pharmaceuticals, Inc.
$155
Janssen Scientific Affairs, LLC
$117
PFIZER INC.
$109
Fresenius Kabi USA, LLC
$82
Mallinckrodt Hospital Products Inc.
$79
Octapharma USA, Inc.
$58
Radius Health, Inc.
$37
Exeltis, USA Inc.
$37
Pacira Therapeutics, Inc.
$20
Kiniksa Pharmaceuticals, Ltd.
$19
Kiniksa Pharmaceuticals International, plc
$19
Oxford Immunotec USA Inc
$17
Fidia Pharma USA Inc.
$16
Organon LLC
$15
Alexion Pharmaceuticals, Inc.
$14
Top 3 companies account for 54.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · EVENITY · Enbrel · HUMIRA · HYMOVIS · IDACIO · ILARIS · KRYSTEXXA · LUPKYNIS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SHINGRIX · SIMPONI ARIA · SKYRIZI · SPEVIGO · T-SPOT.TB8 · TALTZ · TAVNEOS · TREMFYA · Tymlos · Ultomiris · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for nurse practitioner - family in CA.

Looking for a nurse practitioner - family in Bakersfield?
Compare family nurse practitioners in the Bakersfield area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
364
Per 100K population
40.0
County median income
$67,660
Nearest hospital
BAKERSFIELD BEHAVIORAL HEALTHCARE HOSPITAL, LLC
4.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Blankenship is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with low-engagement industry engagement in the top 1% of CA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Blankenship experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Blankenship performed 7,975 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Blankenship receive payments from pharmaceutical companies?
Yes. Dr. Blankenship received a total of $10,884 from 29 companies across 612 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Blankenship's costs compare to other family nurse practitioners in Bakersfield?
Dr. Blankenship's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Blankenship) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →